Question 1

What is BioMarin Pharmaceuticals Inc's WACC?

Accepted Answer

BioMarin Pharmaceuticals Inc (BMRN) has a Weighted Average Cost of Capital (WACC) of 8.11%. This is calculated using a Cost of Equity of 8.91% (via CAPM with a beta of 1.00) and a pre-tax Cost of Debt of 2.00%, with an equity weight of 89.02% in the capital structure.

Question 2

Is BioMarin Pharmaceuticals Inc's WACC high or low?

Accepted Answer

BioMarin Pharmaceuticals Inc's WACC of 8.11% falls within the typical 8-12% range for mid-cap growth companies. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is BioMarin Pharmaceuticals Inc's WACC calculated?

Accepted Answer

BioMarin Pharmaceuticals Inc's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 8.91% is derived from the CAPM model using a beta of 1.00. The pre-tax Cost of Debt (Rd) is 2.00%. The capital structure is 89.02% equity and 10.98% debt.

BioMarin Pharmaceuticals Inc (BMRN) — WACC 分析

WACC 构成

解读

BioMarin Pharmaceuticals Inc（BMRN）WACC：8.11%

WACC计算器

BioMarin Pharmaceuticals Inc（BMRN） WACC 解读

BMRN 公司分析

BMRN DCF 估值

继续做同行对比